{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:05:48Z","timestamp":1792857948860,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-025-02312-5","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:53:59Z","timestamp":1755003239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biomarker discovery in NAFLD: insights from metabolomics and vote counting meta-analysis"],"prefix":"10.1007","volume":"21","author":[{"given":"Pallavi","family":"Mudgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonu","family":"Kumar Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinkal B.","family":"Nith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartikey","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashwant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"2312_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mito.2020.12.010","volume":"57","author":"S Ajaz","year":"2021","unstructured":"Ajaz, S., McPhail, M. J., Gnudi, L., et al. (2021). Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD). Mitochondrion, 57, 119\u2013130. https:\/\/doi.org\/10.1016\/j.mito.2020.12.010","journal-title":"Mitochondrion"},{"issue":"8","key":"2312_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3390\/metabo13080959","volume":"13","author":"AI Amanatidou","year":"2023","unstructured":"Amanatidou, A. I., Mikropoulou, E. V., Amerikanou, C., et al. (2023). Plasma amino acids in NAFLD patients with obesity are associated with steatosis and fibrosis: results from the MAST4HEALTH study. Metabolites, 13(8), 959. https:\/\/doi.org\/10.3390\/metabo13080959","journal-title":"Metabolites"},{"issue":"12","key":"2312_CR4","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.3390\/ijms24129789","volume":"24","author":"L Bertran","year":"2023","unstructured":"Bertran, L., Capellades, J., Abell\u00f3, S., et al. (2023). LC\/MS-Based untargeted metabolomics study in women with nonalcoholic steatohepatitis associated with morbid obesity. International Journal of Molecular Sciences, 24(12), 9789. https:\/\/doi.org\/10.3390\/ijms24129789","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"2312_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/apt.15606","volume":"51","author":"N Cabr\u00e9","year":"2020","unstructured":"Cabr\u00e9, N., Luciano-Mateo, F., Baiges-Gay\u00e0, G., et al. (2020). Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics, 51(3), 374\u2013387. https:\/\/doi.org\/10.1111\/apt.15606","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"2312_CR6","doi-asserted-by":"publisher","first-page":"175628482092390","DOI":"10.1177\/1756284820923904","volume":"13","author":"C Caussy","year":"2020","unstructured":"Caussy, C., Chuang, J. C., Billin, A., et al. (2020). Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology., 13, 1756284820923904. https:\/\/doi.org\/10.1177\/1756284820923904","journal-title":"Therapeutic Advances in Gastroenterology."},{"key":"2312_CR8","doi-asserted-by":"publisher","first-page":"1464865","DOI":"10.3389\/fgene.2024.1464865","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen, J., Rao, H., & Zheng, X. (2024). Identification of novel targets associated with cholesterol metabolism in nonalcoholic fatty liver disease: a comprehensive study using Mendelian randomization combined with transcriptome analysis. Frontiers in Genetics, 15, 1464865. https:\/\/doi.org\/10.3389\/fgene.2024.1464865","journal-title":"Frontiers in Genetics"},{"issue":"4","key":"2312_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/liv.14743","volume":"41","author":"VD de Mello","year":"2021","unstructured":"de Mello, V. D., Sehgal, R., M\u00e4nnist\u00f6, V., Kl\u00e5vus, A., Nilsson, E., Perfilyev, A., Kaminska, D., Miao, Z., Pajukanta, P., Ling, C., Hanhineva, K., & Pihlajam\u00e4ki, J. (2021). Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids. Liver International: Official Journal of the International Association for the Study of the Liver, 41(4), 754\u2013763. https:\/\/doi.org\/10.1111\/liv.14743","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"issue":"1","key":"2312_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3350\/cmh.2021.0205","volume":"28","author":"H El Jamaly","year":"2022","unstructured":"El Jamaly, H., Eslick, G. D., & Weltman, M. (2022). Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. Clinical and Molecular Hepatology, 28(1), 52\u201366. https:\/\/doi.org\/10.3350\/cmh.2021.0205","journal-title":"Clinical and Molecular Hepatology"},{"key":"2312_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144549","volume":"742","author":"G Feng","year":"2020","unstructured":"Feng, G., Li, X. P., Niu, C. Y., et al. (2020). Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Gene, 742, Article 144549. https:\/\/doi.org\/10.1016\/j.gene.2020.144549","journal-title":"Gene"},{"issue":"9","key":"2312_CR15","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrm1451","volume":"5","author":"AR Fernie","year":"2004","unstructured":"Fernie, A. R., Trethewey, R. N., Krotzky, A. J., & Willmitzer, L. (2004). Metabolite profiling: From diagnostics to systems biology. Nature Reviews Molecular Cell Biology, 5(9), 763\u2013769. https:\/\/doi.org\/10.1038\/nrm1451","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7","key":"2312_CR18","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018). Mechanisms of NAFLD development and therapeutic strategies. Nature Medicine, 24(7), 908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nature Medicine"},{"issue":"1","key":"2312_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini, M., Carli, F., Rosso, C., et al. (2018). Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. Hepatology, 67(1), 145\u2013158. https:\/\/doi.org\/10.1002\/hep.29465","journal-title":"Hepatology"},{"issue":"7","key":"2312_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/nu9070642","volume":"9","author":"M Goffredo","year":"2017","unstructured":"Goffredo, M., Santoro, N., Tric\u00f2, D., Giannini, C., D\u2019Adamo, E., Zhao, H., Peng, G., Yu, X., Lam, T. T., Pierpont, B., Caprio, S., & Herzog, R. I. (2017). A branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease. Nutrients, 9(7), 642. https:\/\/doi.org\/10.3390\/nu9070642","journal-title":"Nutrients"},{"issue":"4","key":"2312_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","volume":"75","author":"P Golabi","year":"2021","unstructured":"Golabi, P., Paik, J. M., AlQahtani, S., Younossi, Y., Tuncer, G., & Younossi, Z. M. (2021). Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from global burden of disease 2009\u20132019. Journal of Hepatology, 75(4), 795\u2013809. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.022","journal-title":"Journal of Hepatology"},{"issue":"10","key":"2312_CR22","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.15252\/emmm.201606798","volume":"8","author":"J Goveia","year":"2016","unstructured":"Goveia, J., Pircher, A., Conradi, L. C., Kalucka, J., Lagani, V., Dewerchin, M., & Carmeliet, P. (2016). Meta-analysis of clinical metabolic profiling studies in cancer: Challenges and opportunities. EMBO Molecular Medicine, 8(10), 1134\u20131142.","journal-title":"EMBO Molecular Medicine"},{"key":"2312_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jmsacl.2021.10.001","volume":"22","author":"D He","year":"2021","unstructured":"He, D., Su, Y., Meng, D., Wang, X., Wang, J., & Ye, H. (2021). A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease. Journal of Mass Spectrometry and Advances in the Clinical Lab, 22, 17\u201325. https:\/\/doi.org\/10.1016\/j.jmsacl.2021.10.001","journal-title":"Journal of Mass Spectrometry and Advances in the Clinical Lab"},{"issue":"1","key":"2312_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12967-021-03223-4","volume":"20","author":"C Hu","year":"2022","unstructured":"Hu, C., Wang, T., Zhuang, X., et al. (2022). Correction to: Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry. Journal of Translational Medicine, 20(1), 24. https:\/\/doi.org\/10.1186\/s12967-021-03223-4","journal-title":"Journal of Translational Medicine"},{"key":"2312_CR27","doi-asserted-by":"publisher","unstructured":"Ji, M., Jo, Y., Choi, S. J.\u00a0et al. (2021) Plasma metabolomics profiling and machining learning-driven prediction of nonalcoholic steatohepatitis. medRxiv\u00a010.24.21265434;\u00a0 https:\/\/doi.org\/10.1101\/2021.10.24.21265434","DOI":"10.1101\/2021.10.24.21265434"},{"key":"2312_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103385","volume":"77","author":"H Jian","year":"2024","unstructured":"Jian, H., Li, R., Huang, X., et al. (2024). Branched-chain amino acids alleviate NAFLD via inhibiting de novo lipogenesis and activating fatty acid \u03b2-oxidation in laying hens. Redox Biology, 77, Article 103385. https:\/\/doi.org\/10.1016\/j.redox.2024.103385","journal-title":"Redox Biology"},{"issue":"3","key":"2312_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan, S. C., Guo, L., Edmison, J., Dasarathy, S., McCullough, A. J., Hanson, R. W., & Milburn, M. (2011). Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism, 60(3), 404\u2013413.","journal-title":"Metabolism"},{"issue":"2","key":"2312_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cld.2015.10.002","volume":"20","author":"P Kanwar","year":"2016","unstructured":"Kanwar, P., & Kowdley, K. V. (2016). The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis. Clinics in Liver Disease, 20(2), 225\u2013243. https:\/\/doi.org\/10.1016\/j.cld.2015.10.002","journal-title":"Clinics in Liver Disease"},{"issue":"2","key":"2312_CR31","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3892\/mmr.2018.9223","volume":"18","author":"T Kawaguchi","year":"2018","unstructured":"Kawaguchi, T., Nakano, D., Oriishi, T., & Torimura, T. (2018). Effects of isomaltulose on insulin resistance and metabolites in patients with non-alcoholic fatty liver disease: A metabolomic analysis. Molecular Medicine Reports, 18(2), 2033\u20132042. https:\/\/doi.org\/10.3892\/mmr.2018.9223","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"2312_CR35","doi-asserted-by":"publisher","first-page":"14200","DOI":"10.1038\/s41598-018-31865-w","volume":"8","author":"A Lovric","year":"2018","unstructured":"Lovric, A., Gran\u00e9r, M., Bjornson, E., et al. (2018). Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome. Scientific Reports, 8(1), 14200. https:\/\/doi.org\/10.1038\/s41598-018-31865-w","journal-title":"Scientific Reports"},{"issue":"23","key":"2312_CR36","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.2174\/0929867330666230516123028","volume":"31","author":"A Mahmoudi","year":"2024","unstructured":"Mahmoudi, A., Butler, A. E., De Vincentis, A., Jamialahmadi, T., & Sahebkar, A. (2024). Microarray-based detection of critical overexpressed genes in the progression of hepatic fibrosis in non-alcoholic fatty liver disease: A protein-protein interaction network analysis. Current Medicinal Chemistry, 31(23), 3631\u20133652. https:\/\/doi.org\/10.2174\/0929867330666230516123028","journal-title":"Current Medicinal Chemistry"},{"issue":"7","key":"2312_CR37","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1111\/liv.12769","volume":"35","author":"VT M\u00e4nnist\u00f6","year":"2015","unstructured":"M\u00e4nnist\u00f6, V. T., Simonen, M., Hyysalo, J., et al. (2015). Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. Liver International, 35(7), 1853\u20131861. https:\/\/doi.org\/10.1111\/liv.12769","journal-title":"Liver International"},{"issue":"3","key":"2312_CR38","doi-asserted-by":"publisher","first-page":"916","DOI":"10.15252\/msb.20167422","volume":"13","author":"A Mardinoglu","year":"2017","unstructured":"Mardinoglu, A., Bjornson, E., Zhang, C., Klevstig, M., S\u00f6derlund, S., St\u00e5hlman, M., & Boren, J. (2017). Personal model-assisted identification of NAD+\u00a0and\u00a0glutathione metabolism as intervention target in NAFLD. Molecular Systems Biology, 13(3), 916.","journal-title":"Molecular Systems Biology"},{"issue":"2","key":"2312_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11306-020-01756-1","volume":"17","author":"M Masarone","year":"2021","unstructured":"Masarone, M., Troisi, J., Aglitti, A., et al. (2021). Untargeted metabolomics as a diagnostic tool in NAFLD: Discrimination of steatosis, steatohepatitis and cirrhosis. Metabolomics, 17(2), 12. https:\/\/doi.org\/10.1007\/s11306-020-01756-1","journal-title":"Metabolomics"},{"issue":"5","key":"2312_CR42","doi-asserted-by":"publisher","first-page":"100477","DOI":"10.1016\/j.jhepr.2022.100477","volume":"4","author":"AJ McGlinchey","year":"2022","unstructured":"McGlinchey, A. J., Govaere, O., Geng, D., et al. (2022). Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. JHEP Reports, 4(5), 100477. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100477","journal-title":"JHEP Reports"},{"issue":"1","key":"2312_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40200-024-01516-1","volume":"24","author":"A Nikparast","year":"2024","unstructured":"Nikparast, A., Razavi, M., Sohouli, M. H., et al. (2024). The association between dietary intake of branched-chain amino acids and the odds of nonalcoholic fatty liver disease among overweight and obese children and adolescents. Journal of Diabetes & Metabolic Disorders, 24(1), 19. https:\/\/doi.org\/10.1007\/s40200-024-01516-1","journal-title":"Journal of Diabetes & Metabolic Disorders"},{"key":"2312_CR44","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1038\/ncomms4128","volume":"5","author":"R Nilsson","year":"2014","unstructured":"Nilsson, R., Jain, M., Madhusudhan, N., et al. (2014). Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nature Communications, 5, 3128. https:\/\/doi.org\/10.1038\/ncomms4128","journal-title":"Nature Communications"},{"key":"2312_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J., McKenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71.","journal-title":"BMJ"},{"issue":"12","key":"2312_CR48","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/hep4.1599","volume":"4","author":"JM Paik","year":"2020","unstructured":"Paik, J. M., Golabi, P., Younossi, Y., Srishord, M., Mishra, A., & Younossi, Z. M. (2020). The growing burden of disability related to nonalcoholic fatty liver disease: Data from the global burden of disease 2007\u20132017. Hepatology Communications, 4(12), 1769\u20131780. https:\/\/doi.org\/10.1002\/hep4.1599","journal-title":"Hepatology Communications"},{"issue":"6","key":"2312_CR51","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/hep.23229","volume":"50","author":"P Puri","year":"2009","unstructured":"Puri, P., Wiest, M. M., Cheung, O., et al. (2009). The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology, 50(6), 1827\u20131838. https:\/\/doi.org\/10.1002\/hep.23229","journal-title":"Hepatology"},{"issue":"7","key":"2312_CR52","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/hep4.1188","volume":"2","author":"M Rebeca","year":"2018","unstructured":"Rebeca, M., Crespo, J., Mart\u00ednez-Arranz, I., et al. (2018). Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. Hepatol Communications, 2(7), 807\u2013820. https:\/\/doi.org\/10.1002\/hep4.1188","journal-title":"Hepatol Communications"},{"issue":"8","key":"2312_CR53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2217\/BMM.15.39","volume":"9","author":"BA Rikke","year":"2015","unstructured":"Rikke, B. A., Wynes, M. W., Rozeboom, L. M., Bar\u00f3n, A. E., & Hirsch, F. R. (2015). Independent validation test of the vote-counting strategy used to rank biomarkers from published studies. Biomarkers in Medicine, 9(8), 751\u2013761. https:\/\/doi.org\/10.2217\/BMM.15.39","journal-title":"Biomarkers in Medicine"},{"issue":"2","key":"2312_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","volume":"20","author":"M Sayiner","year":"2016","unstructured":"Sayiner, M., Koenig, A., Henry, L., & Younossi, Z. M. (2016). Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the united states and the rest of the world. Clinics in Liver Disease, 20(2), 205\u2013214. https:\/\/doi.org\/10.1016\/j.cld.2015.10.001","journal-title":"Clinics in Liver Disease"},{"issue":"4","key":"2312_CR55","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2011.01.031","volume":"55","author":"T Soga","year":"2011","unstructured":"Soga, T., Sugimoto, M., Honma, M., et al. (2011). Serum metabolomics reveals \u03b3-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. Journal of Hepatology, 55(4), 896\u2013905. https:\/\/doi.org\/10.1016\/j.jhep.2011.01.031","journal-title":"Journal of Hepatology"},{"issue":"24","key":"2312_CR57","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.3390\/nu14245355","volume":"14","author":"E Stachowska","year":"2022","unstructured":"Stachowska, E., Maciejewska-Markiewicz, D., Palma, J., et al. (2022). Precision nutrition in NAFLD: Effects of a high-fiber intervention on the serum metabolome of nafd patients-a pilot study. Nutrients, 14(24), 5355. https:\/\/doi.org\/10.3390\/nu14245355","journal-title":"Nutrients"},{"key":"2312_CR67","doi-asserted-by":"publisher","unstructured":"Suvitaival, T. (2020). Lipidomic abnormalities during the pathogenesis of Type 1 diabetes: a quantitative review. Current Diabetes Reports, 20(9), 46. https:\/\/doi.org\/10.1007\/s11892-020-01326-8","DOI":"10.1007\/s11892-020-01326-8"},{"key":"2312_CR64","doi-asserted-by":"publisher","first-page":"601745","DOI":"10.3389\/fendo.2020.601745","volume":"11","author":"J Ye","year":"2020","unstructured":"Ye, J., Lin, Y., Wang, Q., et al. (2020). Integrated multichip analysis identifies potential key genes in the pathogenesis of nonalcoholic steatohepatitis. Front Endocrinology (Lausanne), 11, 601745. https:\/\/doi.org\/10.3389\/fendo.2020.601745","journal-title":"Front Endocrinology (Lausanne)"},{"issue":"1","key":"2312_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"issue":"10","key":"2312_CR66","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","volume":"14","author":"Y Zhou","year":"2016","unstructured":"Zhou, Y., Ore\u0161i\u010d, M., Leivonen, M., et al. (2016). Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites. Clinical Gastroenterology and Hepatology, 14(10), 1463-1472.e6. https:\/\/doi.org\/10.1016\/j.cgh.2016.05.046","journal-title":"Clinical Gastroenterology and Hepatology"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-025-02312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-025-02312-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-025-02312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:42:22Z","timestamp":1761867742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-025-02312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2312"],"URL":"https:\/\/doi.org\/10.1007\/s11306-025-02312-5","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"116"}}